These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2322723)

  • 1. Comparison of oral preparations of heroin and methadone to stabilise opiate misusers as inpatients.
    Ghodse AH; Creighton FJ; Bhat AV
    BMJ; 1990 Mar; 300(6726):719-20. PubMed ID: 2322723
    [No Abstract]   [Full Text] [Related]  

  • 2. Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers.
    Donny EC; Brasser SM; Bigelow GE; Stitzer ML; Walsh SL
    Addiction; 2005 Oct; 100(10):1496-509. PubMed ID: 16185211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot study of a Neuro-Stimulator Device vs. methadone in alleviating opiate withdrawal symptoms.
    Elmoghazy E; Johnson BD; Alling FA
    NIDA Res Monogr; 1989; 95():388-9. PubMed ID: 2701306
    [No Abstract]   [Full Text] [Related]  

  • 4. Feasibility of double-blind clinical trials with oral diacetylmorphine: a randomized controlled phase II study in an inpatient setting.
    Colom Farran J; Casas M; Pérez de Los Cobos J; Del Río M; Roncero C; Castells X; Valero S; Eiroa-Orosa FJ; Batlle F; Trujols J
    Eur Addict Res; 2012; 18(6):279-87. PubMed ID: 22854605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opiate withdrawal symptoms in response to 10-day and 21-day methadone withdrawal programmes.
    Gossop M; Griffiths P; Bradley B; Strang J
    Br J Psychiatry; 1989 Mar; 154():360-3. PubMed ID: 2688778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlordiazepoxide vs. methadone in opiate withdrawal: a preliminary double blind trial.
    Drummond DC; Turkington D; Rahman MZ; Mullin PJ; Jackson P
    Drug Alcohol Depend; 1989 Jan; 23(1):63-71. PubMed ID: 2646089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How should opiate withdrawal be measured?
    Turkington D; Drummond DC
    Drug Alcohol Depend; 1989 Oct; 24(2):151-3. PubMed ID: 2676443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans.
    Donny EC; Walsh SL; Bigelow GE; Eissenberg T; Stitzer ML
    Psychopharmacology (Berl); 2002 May; 161(2):202-12. PubMed ID: 11981600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canadian illicit opiate users' views on methadone and other opiate prescription treatment: an exploratory qualitative study.
    Fischer B; Chin AT; Kuo I; Kirst M; Vlahov D
    Subst Use Misuse; 2002 Mar; 37(4):495-522. PubMed ID: 12064431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of diacetylmorphine versus methadone for the treatment of opioid dependence in women.
    Oviedo-Joekes E; Guh D; Brissette S; Marchand K; Marsh D; Chettiar J; Nosyk B; Krausz M; Anis A; Schechter MT
    Drug Alcohol Depend; 2010 Sep; 111(1-2):50-7. PubMed ID: 20510551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial methadone dose in treating opiate addiction.
    Wang RI; Kochar C; Hasegawa AT; Roh BL
    Int J Addict; 1982 Feb; 17(2):357-63. PubMed ID: 7076369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Bethlem Study on NET: putting the record straight.
    Gossop M; Strang J; Bradley B
    Br J Addict; 1989 Jul; 84(7):818-9. PubMed ID: 2667666
    [No Abstract]   [Full Text] [Related]  

  • 13. Heroin anticraving medications: a systematic review.
    Fareed A; Vayalapalli S; Casarella J; Amar R; Drexler K
    Am J Drug Alcohol Abuse; 2010 Nov; 36(6):332-41. PubMed ID: 20955107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of clinician ratings to self reports of withdrawal during clonidine detoxification of opiate addicts.
    Kosten TR; Rounsaville BJ; Kleber HD
    Am J Drug Alcohol Abuse; 1985; 11(1-2):1-10. PubMed ID: 3904410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outpatient versus inpatient opioid detoxification: a randomized controlled trial.
    Day E; Strang J
    J Subst Abuse Treat; 2011 Jan; 40(1):56-66. PubMed ID: 21036514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined naloxone/methadone preparations for opiate substitution therapy.
    Loimer N; Presslich O; Grünberger J; Linzmayer L
    J Subst Abuse Treat; 1991; 8(3):157-60. PubMed ID: 1960767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outpatient comparison of buprenorphine and methadone maintenance. I. Effects on opiate use and self-reported adverse effects and withdrawal symptomatology.
    Johnson RE; Fudala PJ; Jaffe JH
    NIDA Res Monogr; 1990; 105():585-6. PubMed ID: 1876130
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of buprenorphine and methadone effects on opiate self-administration in primates.
    Mello NK; Bree MP; Mendelson JH
    J Pharmacol Exp Ther; 1983 May; 225(2):378-86. PubMed ID: 6188822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptom complaints of patients prescribed either oral methadone or injectable heroin.
    Dürsteler-MacFarland KM; Fischer DA; Mueller S; Schmid O; Moldovanyi A; Wiesbeck GA
    J Subst Abuse Treat; 2010 Jun; 38(4):328-37. PubMed ID: 20206457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Methadone, clonidine and levomepromazine in the treatment of opiate abstinence syndrome: double-blind clinical trial in heroin-addicted patients admitted to a general hospital for organic pathology].
    Vilalta J; Treserra J; García-Esteve L; García-Giralt M; Cirera E
    Med Clin (Barc); 1987 May; 88(17):674-6. PubMed ID: 3613695
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.